Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$4.65 - $7.23 $28,434 - $44,211
-6,115 Closed
0 $0
Q3 2021

Nov 10, 2021

SELL
$7.41 - $10.99 $35,464 - $52,598
-4,786 Reduced 43.9%
6,115 $47,000
Q1 2021

May 14, 2021

BUY
$7.03 - $16.51 $68,451 - $160,757
9,737 Added 836.51%
10,901 $90,000
Q4 2020

Feb 11, 2021

BUY
$5.76 - $11.95 $6,704 - $13,909
1,164 New
1,164 $8,000

Others Institutions Holding SRNE

About Sorrento Therapeutics, Inc.


  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track O'Shaughnessy Asset Management, LLC Portfolio

Follow O'Shaughnessy Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.